Bolton Medical launched phase II of its U.S. clinical trial for its Treovance abdominal stent graft system and corresponding Navitel delivery system.
The Treovance stent graft is designed to be adaptable and flexible in order to accommodate a wide range of anatomies. The Navitel delivery system includes a proximal clasping system for precise delivery.
The phase II study will treat 150 patients with infrarenal aortic aneurysms, enrolled at 30 institutions located throughout the U.S., according to the press release.
“The 1st phase II Treovance endovascular aneurysm repairs mark an exciting time for Bolton Medical and the investigators involved in this trial," national principal investigator Dr. Matthew Eagleton said in prepared remarks. "Their successful implantation is a credit to the quality of the device and the teams involved in its development and clinical application."